Mesalamine Tablet, Delayed Release
Product Images NDC 0591-2245

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 0591-2245). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

Chemical Structure (Image 1)
Chemical structure diagram of Mesalamine, showing its molecular formula C7H7NO3 and molecular weight of 153.14.*
FDA Label Image

1 (Image 2)

1 (Image 2)
Label for Mesalamine Delayed-Release Tablets, USP 1.2 gram by Actavis Pharma, Inc. The label states the dosage form as delayed-release tablets, available as a 120-count prescription bottle. It includes a photo of an orange tablet imprinted with "WPI 2245" and provides standard storage and pharmacist dispensing instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.